LeadIQ logo
Learn more at LeadIQ.com
Gene Therapy Program | University of Pennsylvania

Gene Therapy Program | University of Pennsylvania Employee Directory

Biotechnology ResearchPennsylvania, United States201-500 Employees

Dedicated to discovery + translational research and led by Dr. James Wilson, the Gene Therapy Program (GTP) at the University of Pennsylvania focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases. 

Dr. Wilson's commitment to patients with rare diseases stems from his days as a graduate student and medical student at the University of Michigan between 1977 and 1984. He was discouraged by the lack of available treatments for rare disease patients, but optimistic that science could yield solutions with his initial focus being gene therapy. He completed his training in Internal Medicine at the Massachusetts General Hospital followed by a postdoctoral fellowship at the Whitehead Institute where he began his work in gene therapy.

After launching his faculty career in the Howard Hughes Medical Institute and the University of Michigan, he moved to the University of Pennsylvania in 1993. Jim’s laboratory has made seminal contributions to the technology of gene transfer and has paved the way for translation of these technologies into the clinic. He has published more than 550 papers and is named on more than 110 patents.

Today, the goals of the Gene Therapy Program are to develop and commercialize transformative, genetic-based therapeutics. These goals are driven by the unmet needs of patients with inherited genetic diseases.

The Gene Therapy Program currently employs more than 350+ full-time employees with an annual operating budget based on funding from a diverse group of public and private sponsors.

Find Gene Therapy Program | University of Pennsylvania employees' phone numbers or email addresses

Gene Therapy Program | University of Pennsylvania Global Highlights

Location
Employees

North America
239

Minus sign iconPlus sign icon
  • United States Of America
    239

Europe
6

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    5
  • Switzerland
    1

Gene Therapy Program | University of Pennsylvania's Leadership

Gene Therapy Program | University of Pennsylvania Employee Metrics

100%
50%
0%
2024
2023
  • Research
  • Operations
  • Manufacturing
  • Information Technology
  • Engineering
  • Other

Contact profiles from Gene Therapy Program | University of Pennsylvania

Name
Title
Contact Info
Location
Last Update

Frequently Asked Questions

What is Gene Therapy Program | University of Pennsylvania known for?

Minus sign iconPlus sign icon
Gene Therapy Program | University of Pennsylvania was founded in 1993 operates in the Biotechnology Research industry. The company's main headquarters is located in 125 S 31st St Philadelphia, Pennsylvania US; you can contact the main corporate office by phone at . Explore Gene Therapy Program | University of Pennsylvania's company overview page for more information.

What is Gene Therapy Program | University of Pennsylvania's most common email format?

Minus sign iconPlus sign icon
Gene Therapy Program | University of Pennsylvania employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Gene Therapy Program | University of Pennsylvania email formats with LeadIQ.

How many employees does Gene Therapy Program | University of Pennsylvania have currently?

Minus sign iconPlus sign icon
Gene Therapy Program | University of Pennsylvania has approximately 201 employees as of October 2024. These team members are located across 2 continents, including North AmericaEurope.

Who are Gene Therapy Program | University of Pennsylvania's key employees and leadership?

Minus sign iconPlus sign icon

As of October 2024, Gene Therapy Program | University of Pennsylvania's key employees include:

  • Chief Technology Officer (cmc Gene Therapy): S. Z. S.
  • Chief Medical Officer: F. C.
  • Executive Director, Orphan Disease Center And Chief Administrative Officer, Gene Therapy Program: M. M.
  • Associate Director, Upstream Process Development: P. J.
  • Executive Director; Transactions & Ip @ Gtp; Associate General Counsel @ Upenn & Penn Medicine: R. H.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.